Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics
暂无分享,去创建一个
Barbara Sitek | Martin Eisenacher | Katrin Marcus | Axel Mosig | Maike Ahrens | Thomas Brüning | Klaus Gerwert | Thomas Behrens | Thilo Bracht | Angela Kallenbach-Thieltges | Frederik Großerueschkamp | B. Sitek | T. Brüning | A. Mosig | K. Gerwert | M. Eisenacher | T. Bracht | T. Behrens | K. Marcus | Dirk Theegarten | C. Kuepper | F. Großerueschkamp | A. Kallenbach-Thieltges | D. Theegarten | Claus Kuepper | Hanna C. Diehl | M. Ahrens | Claus Kuepper | Angela Kallenbach-Thieltges
[1] Paul Dumas,et al. Reflection contributions to the dispersion artefact in FTIR spectra of single biological cells. , 2009, The Analyst.
[2] N. Rifai,et al. Biomarker discovery and validation. , 2006, Clinical chemistry.
[3] A. Gown,et al. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. , 2009, Archives of pathology & laboratory medicine.
[4] Yukiko Nakamura,et al. Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker. , 2012, Journal of proteomics.
[5] Max Diem,et al. A method for the comparison of multi-platform spectral histopathology (SHP) data sets. , 2015, The Analyst.
[6] Lisa Miller,et al. FTIR-microspectroscopy of prion-infected nervous tissue. , 2006, Biochimica et biophysica acta.
[7] E. Petricoin,et al. -Omics and Cancer Biomarkers: Link to the Biological Truth or Bear the Consequences , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[8] Axel Mosig,et al. Automated identification of subcellular organelles by coherent anti-stokes Raman scattering. , 2014, Biophysical journal.
[9] A. Savitzky,et al. Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .
[10] Iver Petersen,et al. Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas , 2012, European Respiratory Journal.
[11] H. Martens,et al. Extended multiplicative signal correction and spectral interference subtraction: new preprocessing methods for near infrared spectroscopy. , 1991, Journal of pharmaceutical and biomedical analysis.
[12] Hugh J. Byrne,et al. Resonant Mie scattering (RMieS) correction of infrared spectra from highly scattering biological samples. , 2010, The Analyst.
[13] Rohit Bhargava,et al. Towards a practical Fourier transform infrared chemical imaging protocol for cancer histopathology , 2007, Analytical and bioanalytical chemistry.
[14] J. Weinstein,et al. Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.
[15] A. Nicholson,et al. L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray. , 2004, Carcinogenesis.
[16] Hesham K. Yosef,et al. Label-Free Raman Spectroscopic Imaging Monitors the Integral Physiologically Relevant Drug Responses in Cancer Cells. , 2015, Analytical chemistry.
[17] Joshua LaBaer,et al. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. , 2013, Journal of proteome research.
[18] Haitao Niu,et al. Stromal proteome expression profile and muscle-invasive bladder cancer research , 2012, Cancer Cell International.
[19] S. Pinder,et al. Histological grading of breast carcinomas: a study of interobserver agreement. , 1995, Human pathology.
[20] Antonella I. Mazur,et al. Molecular pathology via IR and Raman spectral imaging , 2013, Journal of biophotonics.
[21] ROHIT BHARGAVA,et al. Infrared Spectroscopic Imaging: The Next Generation , 2012, Applied spectroscopy.
[22] A. Hjerpe,et al. An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma. , 2000, American journal of clinical pathology.
[23] Jenny Forshed,et al. Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma , 2013, Molecular & Cellular Proteomics.
[24] Ramon Silva Martins,et al. Malignant pleural mesothelioma. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.
[25] R. Aebersold,et al. Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring , 2013, Clinical Proteomics.
[26] E. Petricoin,et al. Tissue is alive: New technologies are needed to address the problems of protein biomarker pre‐analytical variability , 2009, Proteomics. Clinical applications.
[27] R. Chen,et al. MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer , 2006, The Yale journal of biology and medicine.
[28] G. Collins. The next generation. , 2006, Scientific American.
[29] W. Cho. Proteomics in translational cancer research: biomarker discovery for clinical applications , 2014, Expert review of proteomics.
[30] C. Waltz. Validation study. , 1988, NLN publications.
[31] W. Baumgärtner,et al. A rapid method for gene expression analysis of Borna disease virus in neurons and astrocytes using laser microdissection and real-time RT-PCR. , 2008, Journal of Virological Methods.
[32] Steven A Carr,et al. Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.
[33] A. Fiszer-Kierzkowska,et al. Combining Laser-Assisted Microdissection with/and Immunohistochemistry-RNA Quality of Clinical LCM-Derived Samples , 2013 .
[34] Paul Dumas,et al. Chemical imaging of biological tissue with synchrotron infrared light. , 2006, Biochimica et biophysica acta.
[35] Keith R Bambery,et al. Fourier transform infrared imaging and small angle x-ray scattering as a combined biomolecular approach to diagnosis of breast cancer. , 2008, Medical physics.
[36] Benjamin Bird,et al. Applications of Infrared and Raman Microspectroscopy of Cells and Tissue in Medical Diagnostics: Present Status and Future Promises , 2012 .
[37] E. Diamandis,et al. Toward an integrated pipeline for protein biomarker development. , 2015, Biochimica et biophysica acta.
[38] E. Petricoin,et al. The role of proteomics in prostate cancer research: biomarker discovery and validation. , 2013, Clinical biochemistry.
[39] Christoph Krafft,et al. Disease recognition by infrared and Raman spectroscopy , 2009, Journal of biophotonics.
[40] Rohit Bhargava,et al. Using Fourier transform IR spectroscopy to analyze biological materials , 2014, Nature Protocols.
[41] Noel W Clarke,et al. FTIR microspectroscopy of selected rare diverse sub‐variants of carcinoma of the urinary bladder , 2013, Journal of biophotonics.
[42] Paul Dumas,et al. Resonant Mie scattering in infrared spectroscopy of biological materials--understanding the 'dispersion artefact'. , 2009, The Analyst.
[43] G. Ginsburg,et al. The path to personalized medicine. , 2002, Current opinion in chemical biology.
[44] A. Mosig,et al. Label-free classification of colon cancer grading using infrared spectral histopathology. , 2016, Faraday discussions.
[45] Robert F. Bonner,et al. Laser Capture Microdissection: Molecular Analysis of Tissue , 1997, Science.
[46] Avrum Spira,et al. Gene expression in lung adenocarcinomas of smokers and nonsmokers. , 2003, American journal of respiratory cell and molecular biology.
[47] Claudio Bianchi,et al. Malignant mesothelioma: global incidence and relationship with asbestos. , 2007, Industrial health.
[48] Paul Bassan,et al. Large scale infrared imaging of tissue micro arrays (TMAs) using a tunable Quantum Cascade Laser (QCL) based microscope. , 2014, The Analyst.
[49] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[50] B. Sitek,et al. Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells* , 2016, Molecular & Cellular Proteomics.
[52] Thomas Brüning,et al. Marker-free automated histopathological annotation of lung tumour subtypes by FTIR imaging. , 2015, The Analyst.
[53] Max Diem,et al. Immunohistochemistry, histopathology and infrared spectral histopathology of colon cancer tissue sections , 2013, Journal of biophotonics.
[54] M. Pilling,et al. Fundamental Developments in Infrared Spectroscopic Imaging for Biomedical Applications , 2016 .
[55] H. Martens,et al. Light scattering and light absorbance separated by extended multiplicative signal correction. application to near-infrared transmission analysis of powder mixtures. , 2003, Analytical chemistry.
[56] Ping-Pin Zheng,et al. Video-Coupled Laser Capture Microdissection Using the PALM MicroBeam: A Powerful Approach for Live Digital Data Communications in Biomedical Research and Education , 2013 .
[57] Daniel Niedieker,et al. Colocalization of fluorescence and Raman microscopic images for the identification of subcellular compartments: a validation study. , 2015, The Analyst.
[58] R. Stahel,et al. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.